S. Pullan

发表

In vivo imaging of human colon cancer xenografts in immunodeficient mice using a guanylyl cyclase C--specific ligand.

S. Waldman, A. Cuthbertson, R. Pither, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Investigation of signalling cascades induced by neurotrophic synaptolepis factor K7 reveals a critical role for novel PKCε.

N. de Kimpe, M. Čík, K. Van Kolen, 2013, European journal of pharmacology.

Gene expression profiles highlight adaptive brain mechanisms in corticotropin releasing factor overexpressing mice.

X. Langlois, T. Steckler, M. Stenzel-Poore, 2004, Brain research. Molecular brain research.

Mastoparan causes cell permeabilisation and delayed activation of DNA synthesis in Swiss 3T3 fibroblasts.

S. Pennington, S. Pullan, 1996, Cellular signalling.

JNJ-20788560 [9-(8-Azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic Acid Diethylamide], a Selective Delta Opioid Receptor Agonist, Is a Potent and Efficacious Antihyperalgesic Agent That Does Not Produce Respiratory Depression, Pharmacologic Tolerance, or Physical Dependence

T. Meert, P. Wade, Sui-Po Zhang, 2009, Journal of Pharmacology and Experimental Therapeutics.

MINI-REVIEW Nociceptive and behavioural sensitisation by protein kinase Ce signalling in the CNS

J. Neefs, K. V. Kolen, F. Dautzenberg, 2008 .

Nociceptive and behavioural sensitisation by protein kinase Cɛ signalling in the CNS

J. Neefs, F. Dautzenberg, K. Van Kolen, 2007 .

4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective δ-opioid agonists

T. Meert, J. M. Alonso, T. Steckler, 2006 .

4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives, a novel class of selective delta-opioid agonists.

T. Meert, J. M. Alonso, T. Steckler, 2006, Bioorganic & medicinal chemistry letters.

Nociceptive and behavioural sensitisation by protein kinase Cepsilon signalling in the CNS.

J. Neefs, F. Dautzenberg, K. Van Kolen, 2008, Journal of neurochemistry.

Tricyclic isoxazolines: identification of R226161 as a potential new antidepressant that combines potent serotonin reuptake inhibition and alpha2-adrenoceptor antagonism.

M. Bakker, A. Megens, X. Langlois, 2007, Bioorganic & medicinal chemistry.

4-Phenyl-4-[1H-imidazol-2-yl]-piperidine derivatives as non-peptidic selective delta-opioid agonists with potential anxiolytic/antidepressant properties. Part 2.

T. Steckler, R. Álvarez, J. Andrés, 2007, Bioorganic & medicinal chemistry letters.

Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium.

J. Hickman, J. Tilly, C. Dive, 1996, Journal of cell science.